{"id":1755,"date":"2015-06-01T12:10:54","date_gmt":"2015-06-01T10:10:54","guid":{"rendered":"http:\/\/www.satt.fr\/?p=1755"},"modified":"2017-11-13T16:57:34","modified_gmt":"2017-11-13T15:57:34","slug":"signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/","title":{"rendered":"Signature d&#8217;une licence entre la SATT Aquitaine et la start-up ProGeLife dans le domaine de la sant\u00e9"},"content":{"rendered":"<p><strong>La start-up Progelife a sign\u00e9 un accord de licence avec Aquitaine Science Transfert<sup>\u00ae<\/sup> pour l\u2019exploitation exclusive de la technologie issue du projet INHNOX, dans le domaine de la sant\u00e9. Cette licence permettra \u00e0 Progelife de d\u00e9velopper, obtenir les autorisations r\u00e9glementaires, fabriquer et commercialiser des produits de sant\u00e9. Ils concernent le traitement de certains cancers comme celui de la peau ou encore certaines pathologies rares telles que xeroderma pigmentosum <\/strong>(<em>voir encadr\u00e9<\/em>)<strong>, ainsi que des produits de dermocosm\u00e9tique pour la pr\u00e9vention et le traitement du vieillissement cutan\u00e9.<\/strong><\/p>\n<p>Bient\u00f4t parvenu au terme de sa maturation, ce projet a fait l\u2019objet d\u2019un <strong>co-d\u00e9veloppement<\/strong> entre ses inventeurs au sein de <strong>l\u2019\u00e9quipe de dermatologie<\/strong> du Dr Hamid Rezvani et du Pr Alain Ta\u00efeb du laboratoire de l\u2019universit\u00e9 de Bordeaux \/ INSERM \u00ab Bioth\u00e9rapies des maladies g\u00e9n\u00e9tiques et cancers \u00bb, dirig\u00e9e par le Professeur Hubert de Verneuil, et l\u2019\u00e9quipe scientifique de <strong>ProGeLife<\/strong>, cofond\u00e9e et dirig\u00e9e par Christophe Hubert. En parall\u00e8le de l\u2019\u00e9tablissement de la preuve de concept par le laboratoire, la soci\u00e9t\u00e9 Progelife a initi\u00e9 le d\u00e9veloppement industriel du projet.<\/p>\n<p>La <strong>technologie<\/strong> repose sur des peptides de petite taille, inhibiteurs de l\u2019enzyme NOX1, cibl\u00e9s \u00e0 partir d\u2019un travail exp\u00e9rimental sur une maladie rare, le xeroderma pigmentosum, qui fait partie des maladies prises en charge au Centre de R\u00e9f\u00e9rence pour les Maladies Rares de la Peau du CHU de Bordeaux, dirig\u00e9 par le Pr Ta\u00efeb. L\u2019activation de NOX1 intervient \u00e0 deux niveaux, dans le d\u00e9clenchement des cancers mais aussi dans la persistance des tumeurs. Les applications th\u00e9rapeutiques de ces peptides seront la pr\u00e9vention et le traitement de ces cancers, en particulier au cours du xeroderma pigmentosum, maladie pour laquelle l\u2019\u00e9quipe dermatologie a obtenu le label EMA \u00ab m\u00e9dicament orphelin \u00bb en 2014.<\/p>\n<p>Les avanc\u00e9es du projet sont tr\u00e8s encourageantes car le peptide inhibiteur de NOX1 a des effets antivieillissement cutan\u00e9 tr\u00e8s marqu\u00e9s sur mod\u00e8le animal, avec des r\u00e9sultats tr\u00e8s prometteurs obtenus en parall\u00e8le pour la photoprotection vis \u00e0 vis des rayonnements ultraviolets.<\/p>\n<p>Pour Christophe Hubert, Directeur G\u00e9n\u00e9ral de ProGeLife, la strat\u00e9gie est <em>&#8221; de d\u00e9velopper des solutions th\u00e9rapeutiques pour lutter &#8221; &#8230;&#8230;<\/em><em> <a href=\"https:\/\/ast-innovations.com\/wp-content\/uploads\/CP_Licence_ProgeLife_01062015.pdf\" target=\"_blank\" rel=\"noopener\">Lire la suite en version pdf<\/a> <\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La start-up Progelife a sign\u00e9 un accord de licence avec Aquitaine Science Transfert\u00ae pour l\u2019exploitation exclusive de la technologie issue du projet INHNOX, dans le domaine de la sant\u00e9. Cette licence permettra \u00e0 Progelife de d\u00e9velopper, obtenir les autorisations r\u00e9glementaires, fabriquer et commercialiser des produits de sant\u00e9. Ils concernent le traitement de certains cancers comme [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[535],"tags":[],"class_list":["post-1755","post","type-post","status-publish","format-standard","hentry","category-reussites"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Signature d&#039;une licence entre la SATT Aquitaine et la start-up ProGeLife dans le domaine de la sant\u00e9 - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"redacteur SATT\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/\"},\"author\":{\"name\":\"redacteur SATT\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a6836c00a1284a8188e1a05deb2a5e5c\"},\"headline\":\"Signature d&#8217;une licence entre la SATT Aquitaine et la start-up ProGeLife dans le domaine de la sant\u00e9\",\"datePublished\":\"2015-06-01T10:10:54+00:00\",\"dateModified\":\"2017-11-13T15:57:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/\"},\"wordCount\":404,\"articleSection\":[\"R\u00e9ussites\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/\",\"url\":\"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/\",\"name\":\"Signature d'une licence entre la SATT Aquitaine et la start-up ProGeLife dans le domaine de la sant\u00e9 - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"datePublished\":\"2015-06-01T10:10:54+00:00\",\"dateModified\":\"2017-11-13T15:57:34+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a6836c00a1284a8188e1a05deb2a5e5c\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Signature d&rsquo;une licence entre la SATT Aquitaine et la start-up ProGeLife dans le domaine de la sant\u00e9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a6836c00a1284a8188e1a05deb2a5e5c\",\"name\":\"redacteur SATT\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/redacteur\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Signature d'une licence entre la SATT Aquitaine et la start-up ProGeLife dans le domaine de la sant\u00e9 - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/","twitter_misc":{"Written by":"redacteur SATT","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/"},"author":{"name":"redacteur SATT","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a6836c00a1284a8188e1a05deb2a5e5c"},"headline":"Signature d&#8217;une licence entre la SATT Aquitaine et la start-up ProGeLife dans le domaine de la sant\u00e9","datePublished":"2015-06-01T10:10:54+00:00","dateModified":"2017-11-13T15:57:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/"},"wordCount":404,"articleSection":["R\u00e9ussites"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/","url":"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/","name":"Signature d'une licence entre la SATT Aquitaine et la start-up ProGeLife dans le domaine de la sant\u00e9 - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"datePublished":"2015-06-01T10:10:54+00:00","dateModified":"2017-11-13T15:57:34+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a6836c00a1284a8188e1a05deb2a5e5c"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/signature-dune-licence-entre-la-satt-aquitaine-et-la-start-up-progelife-dans-le-domaine-de-la-sante\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Signature d&rsquo;une licence entre la SATT Aquitaine et la start-up ProGeLife dans le domaine de la sant\u00e9"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/a6836c00a1284a8188e1a05deb2a5e5c","name":"redacteur SATT","url":"https:\/\/www.satt.fr\/en\/author\/redacteur\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/1755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=1755"}],"version-history":[{"count":1,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/1755\/revisions"}],"predecessor-version":[{"id":4775,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/1755\/revisions\/4775"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=1755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=1755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=1755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}